Thus, 16 weeks of n-3 supplementation and of RT alone, but not in combination, decreased myostatin circulating levels in postmenopausal women with overweight/obesity in the absence of changes in skeletal muscle mass. The gene discussed is MSTN; the disease is obesity disorder.